This inventor holds 1 USPTO granted patent. Top assignees: Greensogna, Inc., National Institute of Advanced Industrial Science and Technology. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2008
Title: Keiichirou Hiratsu: Innovator in Gene Regulation
Introduction
Keiichirou Hiratsu is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of gene regulation through his innovative research and inventions. His work focuses on the development of peptides and proteins that can effectively modulate gene expression.
Latest Patents
Hiratsu holds a patent for a "Gene and peptide for transcriptional repressor." This invention relates to a peptide or protein capable of converting a transcription factor into a transcriptional repressor. The patent describes a gene encoding such peptide or protein, a chimeric protein in which the peptide is fused to a transcription factor, and a recombinant vector containing the chimeric gene. The peptide is notably short, allowing for easy synthesis and effective repression of specific gene transcription. This technology has potential applications in various fields, including cancer research and the regulation of pigment-metabolic enzymes.
Career Highlights
Throughout his career, Keiichirou Hiratsu has worked with esteemed organizations such as the National Institute of Advanced Industrial Science and Technology and Greensogna, Inc. His experience in these institutions has contributed to his expertise in gene regulation and biotechnology.
Collaborations
Hiratsu has collaborated with notable professionals in his field, including Masaru Takagi. These partnerships have furthered his research and development efforts in innovative gene regulation technologies.
Conclusion
Keiichirou Hiratsu is a pioneering inventor whose work in gene regulation has the potential to impact various scientific fields. His innovative approaches to transcriptional repression highlight the importance of biotechnology in addressing complex biological challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile